Biomedical R & D Outsourcing

CRO means the larger scope of business of drug discovery, preclinical research, drug economics, I-IV clinical trials, experimental design, researchers, and the choice of experimental units, audit, inspection, data management and analysis, pharmacogenomics, information , clinical documentation, policies and regulations consultation, production and packaging, promotion, marketing, product launches and sales support and business consultation, etc. Biomedical CRO originated in the 20th century, the United States 80, After World War II the United States to increase understanding of drug development, a new wave of innovation and the rise of biomedical, pharmaceutical research and development requirements and costs increased year by year, as well as intellectual property protection law and regulation gave birth to biomedical CRO is to be elected. After World War II the United States to increase understanding of drug development, a new wave of innovation and the rise of biomedical, pharmaceutical research and development requirements and costs increased year by year, as well as intellectual property protection law and regulation gave birth to biomedical CRO is to be elected CRO market in the U.S. and Europe countries, but thanks to medical research and development costs continue to increase, the developed countries began to biomedical CRO market to developing countries, China and India into a developed country first choice for the transfer. Biomedical CRO in China starting later than in more developed countries, but also later in the developing countries,-India. However, bio-pharmaceutical CRO in China in recent years more than 30% a year growth rate, and even some people predict that China will in 2010 biomedical R & D outsourcing will exceed India. How can sound undertake biomedical CRO market in China are now facing a major problem.In this paper, the basis of biomedical CRO, and explained the connotation of biomedical CRO as well as its close to the core business, the business is difficult to price, a large outsourcing business uncertainty and contractual features help CRO. CRO main role is to increase the use of capital efficiency, risk sharing, and reduce drug-market cycles and industry to break the traditional boundaries. The next article analyzes the domestic and foreign outsourcing of the development of biomedical R & D Status. .Description In order to achieve the technology to catch up, technology transfer, in order to compensate for incomplete corporate resources, in order to deal with complex biomedical R & D activities, CRO willing to conduct biomedical approach to research and development activities. In the future, the world's biomedical CRO will be more and more toward the market and transfer to developing countries, more and more business, the outsourcing of biomedical research and development organization of technical forces have been strengthened, and the biomedical research enterprise will continue through outsourcing alliances integration trend.In order to better development of China's biomedical industry, in order to better undertake the completion of biomedical CRO market, foreign task, adopt high-tech zones in China as the core idea of the establishment in the biomedical park in China with Chinese characteristics, bio-medicine R & D outsourcing company strategy. Chengdu Hi-tech Zone is the development of China's biomedical industry better high-tech zones, representative. High-tech zone of Chengdu as an example of the establishment of the district in Chengdu High-tech biomedical research and development outsourcing company's strengths, weaknesses, opportunities and threats. Finally the tech. Development Zone in biomedical CRO industries comments a little reference.